The Readout Loud

Episode #4 - Mr. Drug CEO doesn't go to DC, billionaires fighting drug prices, a biotech report card

Share this episode
Anyone with this link can open it.
Share Link
Start at 0:00

This episode isn’t summarized yet

Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.

Show notes

Why aren't pharma CEOs getting hauled into Congress? Which biotech companies got a failing grade this quarter? And why is there no Kelley Blue Book for the price tag of a medicine?

Couldn't load the audio. A blocker may be stopping the show's tracking links. Open the file